2016 medical and health industry mergers and acquisitions

A few days ago, "Internet + Rehabilitation Medical " represented the big health field and became one of the goals of joint investment and mergers and acquisitions. Dongcheng Pharmaceutical, Tianyao, Fosun Pharma, Huashen Group and Renfu Medicine all have similar actions.

In fact, in the past year, China’s mergers and acquisitions have been booming, showing explosive growth. In the domestic pharmaceutical market, more than 10 listed pharmaceutical companies have set up medical industry M&A funds, and the scale of M&A funds has already exceeded 10 billion. At the same time, some listed companies have also laid out the medical market across the border by setting up investment funds and directly purchasing pharmaceutical targets. The pharmaceutical industry mergers and acquisitions are unprecedentedly active.

Zeng Haiwei, director of the China Business School's Director of Operations Research Center, said in an interview with the China Sankei Shimbun News that the development of pharmaceutical companies will move from fragmentation, extensive and barbaric development to a standardized, large-scale and high-end development. Development mode, which will promote the healthy and rapid development of China's medical industry.

Policy boosts mergers and acquisitions integration “Under the policy push, the merger and acquisition of medical industry is a big trend. The establishment of funds by pharmaceutical companies to participate in mergers and acquisitions is actually grabbing market share.” Wang Jun, a researcher at China Research Institute, accepted the “China Sankei Shimbun” The reporter said in an interview.

It is worth mentioning that in recent years, the policy on the medical and health industry is more intensive. As early as 2013, the State Council promulgated the "Several Opinions on Promoting the Development of Health Service Industry", suggesting that by 2020, the total size of the medical and health industry will exceed 8 trillion yuan.

In 2014, the “Guiding Opinions on Accelerating the Merger and Reorganization of Key Industry Enterprises” jointly issued by 12 departments including the Ministry of Industry and Information Technology clearly pointed out that to achieve the scale and intensification of basic drug production, a number of substandard medical enterprises that were not up to standard were merged. Or facing elimination, industry changes and adjustments, leading to frequent mergers and acquisitions.

The guidance also clarifies that by 2015, the sales revenue of the top 100 pharmaceutical companies will account for more than 50% of the total industry, and the market share of the top 20 companies in the sales of major staple drugs will reach 80%, achieving the scale of basic drug production. intensification.

Wang Jun believes that by 2016, when the GMP reform limit is reached, many high-quality targets will be released, so the medical and health industry enterprises are now preparing for mergers and acquisitions.

From the perspective of pharmaceutical companies, the reporter learned that at present, there are four or five thousand domestic pharmaceutical companies, but the scale is generally small. The largest enterprises are sales of tens of billions and market value of 780 billion.

“Compared with the market value of hundreds of billions of developed countries, the gap is still relatively large, so it is still necessary to carry out M&A integration. Improve market competitiveness.” Wang Jun said that encouraging social capital to run medical treatment and drug approval registration management is becoming more stringent and in large numbers. The expiration of patented drugs has promoted the merger of the pharmaceutical and health industry.

Along with the rapid development of China's economy, the public's emphasis on medical health is also increasing. Zeng Haiwei said that China's medical and health market is currently entering a stage of rapid development. The pharmaceutical market is a rigid market, and the scale of the healthy market is growing rapidly. The involvement of social capital, the low risk of capital investment, and the high rate of return have made many social capitals invested in this industry, accelerating the mergers and acquisitions and rapid development of medical enterprises.

Mini Laser Distance Meter

JRT mini laser rangefinder is a portable and cute diastimeter, which is a very convenient measurement tool. We offers best quality Handheld Laser Distance Meter, accuracy laser range finder, best laser distance measurer, bluetooth Laser Distance Meter.

Our Professional R&D team has over 15 years of experience on the laser and measurement field , so we have made out the mini size laser distance module in the world. For the miniature laser distance meter, whether used for interior design, construction, real estate, the D30 styel is engineered to meet your measuring needs with six calculation functions: Area, Height, Volume, Area Summation, Addition/Subtraction, and indirect Pythagorean Theorem.

Small Laser Distance Module,Mini Laser Measure,Smallest Oem Laser Modules,Mini Laser Distance Meter

Chengdu JRT Meter Technology Co., Ltd , https://www.rangingsensor.com